Patents-Review.com
🔗 Permalink
Inventor profile of:

Trason Thode

City:

Phoenix, Arizona

Country:

United States

Published Applications:

10

Last publication date:

2026-05-14

Top Assignees for applications by Trason Thode

The entities that hold a legal rights for patent applications filed by inventor Thode Trason:

Recent patent applications by Thode Trason

Trason Thode from Phoenix, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14
US20260132158A1
Chemistry; metallurgy

PHENYL OXY AMIDE KINASE INHIBITORS

 #2 | 2025-03-27
US20250099493A1
Human necessities

PHOSPHONATES AS INHIBITORS OF ENPP1 AND CDNP

 #3 | 2025-03-20
US20250092018A1
Chemistry; metallurgy

INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF

 #4 | 2024-02-01
US20240034727A1
Chemistry; metallurgy

IMIDAZOLE COMPOUNDS AS INHIBITORS OF ENPP1

 #5 | 2023-11-02
US20230348475A1
Chemistry; metallurgy

IMIDAZOPYRIDAZINE AND IMIDAZOPYRAZINE COMPOUNDS AS INHIBITORS OF CDK7

 #6 | 2023-06-15
US20230183212A1
Chemistry; metallurgy

Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof

 #7 | 2022-05-12
US20220144841A1
Chemistry; metallurgy

TRISUBSTITUTED PYRAZOLO [1,5-A] PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS

 #8 | 2021-08-19
US20210253556A1
Chemistry; metallurgy

Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof

 #9 | 2020-02-06
US20200039979A1
Chemistry; metallurgy

Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

 #10 | 2019-01-31
US20190031655A1
Chemistry; metallurgy

Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics
InventorID:

2414713 ⎘